MedEquities Realty Trust, a recently-formed REIT focused on health care properties in Texas and California, raised $239 million by offering 19.9 million shares at $12, the low end of the range of $12 to $14. MedEquities Realty Trust plans to list on the NYSE...read more
While markets got a rough start to the week on the heels of the UK Referendum vote, both US and global markets rebounded sharply during the remainder of the week. The S&P 500 closed the week at 2,103, just ten points shy of its close before the vote....read more
Global Medical REIT, a health care REIT with a portfolio of 12 facilities, raised $130 million by offering 13 million shares at $10, the low end of the range of $10 to $12. Global Medical REIT plans to list on the NYSE under the symbol GMRE. Wunderlich...read more
In the last week before Independence Day weekend, there are a few small IPOs to cap off a second quarter that was much improved from the lackluster first quarter. Syros Pharmaceuticals looks to continue the trend of insider buying on biotechs....read more
MedEquities Realty Trust prices IPO at $12, the low end of the range
MedEquities Realty Trust, a recently-formed REIT focused on health care properties in Texas and California, raised $239 million by offering 19.9 million shares at $12, the low end of the range of $12 to $14. MedEquities Realty Trust plans to list on the NYSE...read more
US IPO Weekly Recap: 2 deals price; markets shake off UK vote
While markets got a rough start to the week on the heels of the UK Referendum vote, both US and global markets rebounded sharply during the remainder of the week. The S&P 500 closed the week at 2,103, just ten points shy of its close before the vote....read more
Global Medical REIT prices IPO at $10, the low end of the range
Global Medical REIT, a health care REIT with a portfolio of 12 facilities, raised $130 million by offering 13 million shares at $10, the low end of the range of $10 to $12. Global Medical REIT plans to list on the NYSE under the symbol GMRE. Wunderlich...read more
US IPO Week Ahead: Two biotechs, one device maker and one health care REIT
In the last week before Independence Day weekend, there are a few small IPOs to cap off a second quarter that was much improved from the lackluster first quarter. Syros Pharmaceuticals looks to continue the trend of insider buying on biotechs....read more